CRIS Current Research Information System

DIEMBERGER, IGOR
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.501
AS - Asia 16.181
EU - Europa 12.389
SA - Sud America 996
Continente sconosciuto - Info sul continente non disponibili 859
AF - Africa 784
OC - Oceania 27
Totale 47.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.242
VN - Vietnam 4.427
SG - Singapore 4.363
CN - Cina 3.804
IT - Italia 2.546
GB - Regno Unito 2.445
DE - Germania 1.806
NL - Olanda 1.298
HK - Hong Kong 1.200
SE - Svezia 833
FR - Francia 808
IN - India 742
BR - Brasile 712
RU - Federazione Russa 679
UA - Ucraina 657
KR - Corea 398
IE - Irlanda 363
JP - Giappone 286
BD - Bangladesh 277
CI - Costa d'Avorio 256
FI - Finlandia 240
ZA - Sudafrica 209
EE - Estonia 198
AR - Argentina 128
CA - Canada 127
TG - Togo 112
BG - Bulgaria 99
ID - Indonesia 96
PH - Filippine 90
SC - Seychelles 89
CH - Svizzera 88
JO - Giordania 86
AT - Austria 71
IQ - Iraq 70
MX - Messico 62
TH - Thailandia 61
PL - Polonia 55
TR - Turchia 44
PK - Pakistan 43
TW - Taiwan 39
BE - Belgio 38
NG - Nigeria 38
EC - Ecuador 37
ES - Italia 33
CO - Colombia 30
IR - Iran 30
SA - Arabia Saudita 28
CL - Cile 27
GR - Grecia 27
AU - Australia 25
PY - Paraguay 22
JM - Giamaica 19
EG - Egitto 18
RO - Romania 18
UZ - Uzbekistan 17
VE - Venezuela 16
MA - Marocco 14
PE - Perù 12
TN - Tunisia 12
LT - Lituania 11
UY - Uruguay 11
MY - Malesia 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
DO - Repubblica Dominicana 9
LB - Libano 9
DK - Danimarca 8
KE - Kenya 8
PT - Portogallo 8
AZ - Azerbaigian 7
AL - Albania 6
EU - Europa 6
GT - Guatemala 6
IL - Israele 6
MN - Mongolia 6
NP - Nepal 6
OM - Oman 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
DZ - Algeria 5
HR - Croazia 5
HU - Ungheria 5
KZ - Kazakistan 5
PR - Porto Rico 5
SI - Slovenia 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
HN - Honduras 4
NO - Norvegia 4
SN - Senegal 4
SV - El Salvador 4
AO - Angola 3
LU - Lussemburgo 3
NI - Nicaragua 3
SM - San Marino 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CY - Cipro 2
Totale 46.841
Salva come PNG Salva come JPEG
Città #
Singapore 3.052
Southend 2.107
Ashburn 1.661
Fairfield 1.365
San Jose 1.276
Hong Kong 1.138
Ho Chi Minh City 966
Hefei 865
Hanoi 744
Santa Clara 739
Chandler 727
Woodbridge 671
Kerkrade 652
Wilmington 623
Seattle 589
Houston 564
Princeton 563
Dong Ket 497
Jacksonville 454
Cambridge 447
Frankfurt am Main 436
Beijing 428
Council Bluffs 413
Boardman 396
Dublin 364
Seoul 355
Eygelshoven 338
Lauterbourg 336
Ann Arbor 326
Los Angeles 317
Bologna 280
Abidjan 256
Tokyo 246
Westminster 232
New York 220
Milan 219
Nanjing 211
Padova 198
Dallas 195
Helsinki 190
Berlin 173
Rome 158
Buffalo 144
Saint Petersburg 134
Haiphong 128
Jinan 128
Da Nang 127
Shenyang 113
São Paulo 113
Lomé 112
Redondo Beach 105
Sofia 94
Medford 91
San Diego 91
Bremen 88
Changsha 87
The Dalles 86
Turin 85
Bengaluru 84
Amman 82
Mülheim 79
Chicago 72
Guangzhou 71
Munich 70
Nanchang 68
Des Moines 64
Hebei 64
Redmond 61
Bern 57
Mahé 57
Nuremberg 56
Biên Hòa 52
Phoenix 51
Shanghai 51
Tianjin 50
Zhengzhou 49
Jiaxing 47
London 46
Naples 46
Hải Dương 45
Jakarta 43
Hangzhou 41
San Francisco 41
Yubileyny 40
Can Tho 39
Olalla 38
Bari 36
Warsaw 36
Abeokuta 35
Ninh Bình 35
Verona 35
Brussels 34
Ningbo 34
Brooklyn 33
Dearborn 33
Lappeenranta 33
Amsterdam 32
Falkenstein 32
Toronto 32
Florence 31
Totale 29.748
Salva come PNG Salva come JPEG
Nome #
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 1.719
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.119
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 439
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 325
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 311
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 290
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 279
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 267
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 263
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 254
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 251
Automated CO2 angiography: Injection pressure and volume settings 246
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 232
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 232
Atrial fibrillation: it is better to be alone than in bad company! 231
AF burden is important - Fact or fiction? 223
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 223
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry 220
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 218
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 217
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 214
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 208
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 207
Comparison Between a Single-Lead ECG Garment Device and a Holter Monitor: A Signal Quality Assessment 206
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 206
Electrocardiographic remodeling during cardiac resynchronization therapy 204
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 204
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 204
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 203
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 203
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 200
Farmaci antiaritmici 199
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study 198
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 197
Exploring Microphone Technologies for Digital Auscultation Devices 195
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 195
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 194
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 194
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 194
Drug-induced Kounis syndrome: A matter of pharmacovigilance 194
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 192
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 191
Atrial fibrillation ablation: beyond electro-mechanical matters 187
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 185
A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS: The NARROW-CRT Study 184
Wireless Endocardial Atrial (and Ventricular) Sensing with no Implanted Power Source: a Proposal 184
Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only? 183
Implantation of cardioverter-defibrillator: Effects on shoulder function. 181
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 180
Improving Auscultation in Wearable Health Devices Integrating MEMS Microphones and Accelerometers 179
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 179
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 178
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 178
Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients 177
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections 177
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 176
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 176
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 176
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 175
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 175
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 175
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 174
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 172
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 171
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 171
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 170
Is ventricular sensing always right, when it is left? 170
Predictors of long-term survival free from relapses after extraction of infected CIED. 169
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 168
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 168
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 167
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 166
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes 166
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 166
Technical Suitability of Implantable Cardiac Devices for Recreational Diving 165
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 164
Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria 162
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 161
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 161
Self-reported physical activity and major adverse events in patients with atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry 161
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis 160
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 160
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 160
Atrial fibrillation and heart failure: does one epidemic feed he other? 160
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 159
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 159
The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies 159
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase 158
Cardiac resynchronization therapy and cardiac sympathetic function. 157
Long-Term Atrioventricular Block Following Valve Surgery: Electrocardiographic and Surgical Predictors 156
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 156
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations 155
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 154
Phrenic stimulation: a challenge for cardiac resynchronization therapy 154
QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study 153
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 153
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry 152
The QRS interval in patients treated with resynchronization therapy: which value 152
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients 152
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 152
Totale 21.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.808 0 187 262 318 422 252 113 380 165 198 747 764
2022/20234.533 446 563 212 596 269 277 157 237 833 248 349 346
2023/20241.566 125 219 109 116 152 295 92 122 72 111 68 85
2024/20256.574 294 1.236 524 469 1.050 289 349 161 96 402 386 1.318
2025/202617.822 1.658 1.692 1.574 1.233 1.478 1.843 2.279 1.091 2.557 1.180 640 597
2026/20271.490 857 633 0 0 0 0 0 0 0 0 0 0
Totale 47.737